Neurothera Labs Inc (NTLX.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 01/31
(Values in thousands)
| 07-2025 | 04-2025 | 01-2025 | 10-2024 | 07-2024 | |
| Operating Expenses | 17 | 16 | 160 | 16 | 81 |
| Operating Income | -17 | -16 | -160 | -16 | -81 |
| Pre-tax Income | -17 | -16 | -160 | -17 | -81 |
| Net Income Continuous | -17 | -16 | -160 | -17 | -81 |
| Net Income | $-17 | $-16 | $-160 | $-17 | $-81 |
| EPS Basic Total Ops | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 |
| EPS Basic Continuous Ops | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 |
| EPS Diluted Total Ops | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 |
| EPS Diluted Continuous Ops | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 |
| EBITDA(a) | $-17 | $-16 | $-160 | $-16 | $-81 |